Sukumar Nagendran, MD

The president and head of R&D at Taysha Gene Therapies discussed his expectation that younger patients my see even better results with the company’s gene therapy than the adult patients treated so far.

The president and head of R&D at Taysha Gene Therapies discussed positive early results from the first 2 patients treated with gene therapy TSHA-102.

The president and head of R&D at Taysha Gene Therapies discussed the early clinical evaluation of TSHA-102.